Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amantadine in Parkinson's disease (Phase 2, CHU de Toulouse)
2011-005201-75Phase 2Active
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amantadine in Parkinson's disease (PD), sponsored by Centre hospitalier universitaire de Toulouse. Started Jan 2012; status: active.
02
Drugs
amantadine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2011-005201-75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005201-75.